Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
Interstitial lung diseases (ILDs) are some of the first and most serious complications of connective tissue diseases (CTDs). However, the pathogenesis of CTD-related ILDs (CTD-ILDs) is still unclear and their treatment often depends on functional and radiographic disease progression as well as on pa...
Main Authors: | Valeria Nucera, Elisabetta Gerratana, Manuela Giallanza, Laura La Corte, Donatella Sangari |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2021-01-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/efficacy-of-cyclophosphamide-in-treating-connective-tissue-disease-related-interstitial-lung-diseases |
Similar Items
-
Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
by: Wang Pengfei, et al.
Published: (2023-11-01) -
Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
by: Gian Luca Erre, et al.
Published: (2021-01-01) -
Efficacy and safety of Chinese herbal medicines combined with cyclophosphamide for connective tissue disease-associated interstitial lung disease: A meta-analysis of randomized controlled trials
by: Xietian Yin, et al.
Published: (2023-02-01) -
Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis
by: D V Bestaev, et al.
Published: (2013-05-01) -
Interstitial pneumonia with autoimmune features
by: Uma Karjigi, et al.
Published: (2021-01-01)